Development of rebamipide-loaded spray-dried microsphere using distilled water and meglumine: physicochemical characterization and pharmacokinetics in rats

References

• Bazeed AY, Essa EA, Nouh A, El Maghraby GM. 2020. Co-processing of nateglinide with meglumine for enhanced dissolution rate: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 46(10):1676–1683.
   PubMed Web of Science ®Google Scholar
• Cho JH, Choi HG. 2020. Development of novel tenofovir disoproxil phosphate salt with stability enhancement and bioequivalence to the commercial tenofovir disoproxil fumarate salt in rats and beagle dogs. Int J Pharm. 576:118957–118964.
   PubMedGoogle Scholar
• Cho JH, Kim JC, Kim HS, Kim DS, Kim KS, Kim YI, Yong CS, Kim JO, Youn YS, Oh KT, et al. 2017. Novel dabigatran etexilate hemisuccinate-loaded polycap: physicochemical characterisation and in vivo evaluation in beagle dogs. Int J Pharm. 525(1):60–70.
   PubMedGoogle Scholar
• Cho JH, Kim YI, Kim DW, Yousaf AM, Kim JO, Woo JS, Yong CS, Choi HG. 2014. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. Eur J Pharm Sci. 54:1–7.
   PubMed Web of Science ®Google Scholar
• Din FU, Choi JY, Kim DW, Mustapha O, Kim DS, Thapa RK, Ku SK, Youn YS, Oh KT, Yong CS, et al. 2017. Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration. Drug Deliv. 24(1):502–510.
   PubMed Web of Science ®Google Scholar
• Din FU, Kim DW, Choi JY, Thapa RK, Mustapha O, Kim DS, Oh YK, Ku SK, Youn YS, Oh KT, et al. 2017. Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater. 54:239–248.
   PubMed Web of Science ®Google Scholar
• Ha J-M, Seo J-W, Kim S-H, Kim J-Y, Park C-W, Rhee Y-S, Park E-S. 2017. Implementation of quality by design for formulation of rebamipide gastro-retentive tablet. AAPS PharmSciTech. 18(8):3129–3139.
   PubMed Web of Science ®Google Scholar
• Heiderscheidt E, Leiviskä T. 2018. Evaluating the influence of pH adjustment on chemical purification efficiency and the suitability of industrial by-products as alkaline agents. J Environ Manage. 213:180–188.
   PubMed Web of Science ®Google Scholar
• Holland EJ, Darvish M, Nichols KK, Jones L, Karpecki PM. 2019. Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review. Ocul Surf. 17(3):412–423.
   PubMed Web of Science ®Google Scholar
• Huang BB, Li GF, Luo JH, Duan L, Nobuaki K, Akira Y. 2008. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier. World J Gastroenterol. 14(31):4928–4937.
   PubMed Web of Science ®Google Scholar
• Jaafar MH, Safi SZ, Tan MP, Rampal S, Mahadeva S. 2018. Efficacy of rebamipide in organic and functional dyspepsia: a systematic review and meta-analysis. Dig Dis Sci. 63(5):1250–1260.
   PubMed Web of Science ®Google Scholar
• Jeong SC, Kim DS, Jin SG, Youn YS, Oh KT, Li DX, Yong CS, Kim JO, Kim KS, Choi HG. 2018. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process. Pharmazie. 73(9):498–502.
   PubMed Web of Science ®Google Scholar
• Kakuda H, Okada T, Otsuka M, Katsumoto Y, Hasegawa T. 2009. Multivariate analysis of DSC-XRD simultaneous measurement data: a study of multistage crystalline structure changes in a linear poly(ethylene imine) thin film. Anal Bioanal Chem. 393(1):367–376.
   PubMed Web of Science ®Google Scholar
• Kim DS, Cho JH, Park JH, Kim JS, Song ES, Kwon J, Giri BR, Jin SG, Kim KS, Choi H-G, et al. 2019. Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate. Int J Nanomedicine. 14:4949–4960.
   PubMed Web of Science ®Google Scholar
• Kim DS, Choi JS, Kim DW, Kim KS, Seo YG, Cho KH, Kim JO, Yong CS, Youn YS, Lim S-J, et al. 2016. Comparison of solvent-wetted and kneaded l-sulpiride-loaded solid dispersions: powder characterization and in vivo evaluation. Int J Pharm. 511(1):351–358.
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim DW, Kim KS, Choi JS, Seo YG, Youn YS, Oh KT, Yong CS, Kim JO, Jin SG, et al. 2016. Development of a novel l-sulpiride-loaded quaternary microcapsule: effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability. Colloids Surf B Biointerfaces. 147:250–257.
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim JS, Lim SJ, Kim JO, Yong CS, Choi HG, Jin SG. 2019. Comparison of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded self-emulsifying granule and solid self-nanoemulsifying drug delivery system: powder property, dissolution and oral bioavailability. Pharmaceutics. 11(8):415–429.
   Web of Science ®Google Scholar
• Kim JC, Kim KS, Kim DS, Jin SG, Kim DW, Kim YI, Park JH, Kim JO, Yong CS, Youn YS, et al. 2016. Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor. Int J Pharm. 506(1-2):93–101.
   PubMed Web of Science ®Google Scholar
• Kim JS, Park JH, Jeong SC, Kim DS, Yousaf AM, Din FU, Kim JO, Yong CS, Youn YS, Oh KT, et al. 2018. Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability. J Microencapsul. 35(5):421–427.
   PubMed Web of Science ®Google Scholar
• Kim KS, Kim JC, Jin SG, Kim DW, Kim DS, Yong CS, Kim JO, Youn YS, Oh KT, Woo JS, et al. 2016. Development of novel prasugrel base microsphere-loaded tablet with enhanced stability: physicochemical characterization and in vivo evaluation in beagle dogs. Colloids Surf B Biointerfaces. 146:754–761.
   PubMed Web of Science ®Google Scholar
• Kim KT, Lee JY, Park JH, Cho HJ, Yoon IS, Kim DD. 2017. Capmul MCM/Solutol HS15-based microemulsion for enhanced oral bioavailability of rebamipide. J Nanosci Nanotechnol. 17(4):2340–2344.
   PubMed Web of Science ®Google Scholar
• Li X, Yang M, Li Y, Gong W, Wang Y, Shan L, Shao S, Gao C, Zhong W. 2017. Formulation and characterization of a ternary inclusion complex containing hydroxypropyl-β-cyclodextrin and meglumine for solubility enhancement of poorly water-soluble ST-246, an anti-smallpox drug. Curr Drug Deliv. 14(8):1130–1143.
   PubMed Web of Science ®Google Scholar
• Mustapha O, Din FU, Kim DW, Park JH, Woo KB, Lim SJ, Youn YS, Cho KH, Rashid R, Yousaf AM, et al. 2016. Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation. J Microencapsul. 33(4):323–330.
   PubMed Web of Science ®Google Scholar
• Mustapha O, Kim KS, Shafique S, Kim DS, Jin SG, Seo YG, Youn YS, Oh KT, Lee BJ, Park YJ, et al. 2016. Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: physicochemical characterization and in vivo evaluation. Colloids Surf B Biointerfaces. 150:216–222.
   PubMed Web of Science ®Google Scholar
• Narala A, Guda S, Veerabrahma K. 2019. Lipid nanoemulsions of rebamipide: formulation, characterization, and in vivo evaluation of pharmacokinetic and pharmacodynamic effects. AAPS PharmSciTech. 20(1):26–34.
   PubMed Web of Science ®Google Scholar
• Park JH, Cho JH, Kim DS, Kim JS, Din FU, Kim JO, Yong CS, Youn YS, Oh KT, Kim DW, et al. 2019. Revaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation. Pharm Dev Technol. 24(6):788–793.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim DS, Mustapha O, Yousaf AM, Kim JS, Kim DW, Yong CS, Youn YS, Oh KT, Lim S-J, et al. 2018. Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: physicochemical characterisation and pharmacokinetics. Colloids Surf B Biointerfaces. 162:420–426.
   PubMed Web of Science ®Google Scholar
• Pradhan R, Tran TH, Choi JY, Choi IS, Choi HG, Yong CS, Kim JO. 2015. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability. Arch Pharm Res. 38(4):522–533.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zou M, An Y, Ji Z, Gao P, Cheng G. 2013. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Drug Dev Ind Pharm. 39(7):996–1004.
   PubMed Web of Science ®Google Scholar
• Simsek C, Dogru M, Shinzawa M, Den S, Kojima T, Iseda H, Suzuki M, Shibasaki Y, Yoshida N, Shimazaki J. 2019. The efficacy of 2% topical rebamipide on conjunctival squamous metaplasia and goblet cell density in dry eye disease. J Ocul Pharmacol Ther. 35(6):350–358.
   PubMed Web of Science ®Google Scholar
• Takano H, Uchida S, Kashiwagura Y, Tanaka S, Hakamata A, Odagiri K, Inui N, Watanabe H, Namiki N. 2019. Preparation of cocoa powder-containing orally disintegrating tablets of rebamipide (rebamipide chocolet) and evaluation of their clinical palatability. Chem Pharm Bull. 67(2):112–119.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Kamiki Y, Makino K. 2018. Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy. Colloids Surf B Biointerfaces. 167:468–473.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Hattori Y, Horie Y, Kamada H, Nagato T, Otsuka M. 2019. Characterization of amorphous solid dispersion of pharmaceutical compound with pH-dependent solubility prepared by continuous-spray granulator. Pharmaceutics. 11(4):159–171.
   Web of Science ®Google Scholar
• Tran PH, Tran TT, Park JB, Min DH, Choi HG, Han HK, Rhee YS, Lee BJ. 2011. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Int J Pharm. 414(1–2):48–55.
   PubMedGoogle Scholar
• Tung NT, Park CW, Oh TO, Kim JY, Ha JM, Rhee YS, Park ES. 2011. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy. J Pharm Pharmacol. 63(12):1539–1547.
   PubMed Web of Science ®Google Scholar
• Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. 2017. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Drug Dev Ind Pharm. 43(2):283–292.
   PubMed Web of Science ®Google Scholar
• Yousaf AM, Kim DW, Kim DS, Kim JO, Youn YS, Cho KH, Yong CS, Choi HG. 2016. Influence of polyvinylpyrrolidone quantity on the solubility, crystallinity and oral bioavailability of fenofibrate in solvent-evaporated microspheres. J Microencapsul. 33(4):365–371.
   PubMed Web of Science ®Google Scholar
• Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, et al. 2016. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int J Nanomedicine. 11:213–221.
   PubMed Web of Science ®Google Scholar